Adjusted estimates for time-to-event endpoints

被引:24
|
作者
Storer, Barry E. [1 ]
Gooley, Ted A. [1 ]
Jones, Michael P. [2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Iowa, Iowa City, IA USA
关键词
Cox regression; Kaplan-Meier; Adjusted survival; Cumulative incidence;
D O I
10.1007/s10985-008-9098-9
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
In the analysis of retrospective data or when interpreting results from a single-arm phase II clinical trial relative to historical data, it is often of interest to show plots summarizing time-to-event outcomes comparing treatment groups. If the groups being compared are imbalanced with respect to factors known to influence outcome, these plots can be misleading and seemingly incompatible with results obtained from a regression model that accounts for these imbalances. We consider ways in which covariate information can be used to obtain adjusted curves for time-to-event outcomes. We first review a common model-based method and then suggest another model-based approach that is not as reliant on model assumptions. Finally, an approach that is partially model free is suggested. Each method is applied to an example from hematopoietic cell transplantation.
引用
收藏
页码:484 / 495
页数:12
相关论文
共 50 条
  • [21] Meta-analysis of clinical trials with competing time-to-event endpoints
    Meddis, Alessandra
    Latouche, Aurelien
    Zhou, Bingqing
    Michiels, Stefan
    Fine, Jason
    [J]. BIOMETRICAL JOURNAL, 2020, 62 (03) : 712 - 723
  • [22] Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
    Uozumi, Ryuji
    Yada, Shinjo
    Kawaguchi, Atsushi
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)
  • [23] Guidelines for time-to-event endpoints' definitions in cancer randomized controlled trials (RCTs) for breast cancer - results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
    Gourgou-Bourgade, S.
    Dabakuyo-Yonli, S.
    Cameron, D.
    Cardoso, F.
    Poortmans, P.
    Asselain, B.
    Azria, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S441 - S442
  • [24] Familywise error for multiple time-to-event endpoints in a group sequential design
    Thomsen, Henrik F.
    Lausvig, Nanna L.
    Pipper, Christian B.
    Andersen, Soren
    Damgaard, Lars H.
    Emerson, Scott S.
    Ravn, Henrik
    [J]. STATISTICS IN MEDICINE, 2024, 43 (18) : 3417 - 3431
  • [25] Trial Design with Win Statistics for Multiple Time-to-Event Endpoints with Hierarchy
    Barnhart, Huiman X.
    Lokhnygina, Yuliya
    Matsouaka, Roland A.
    Rockhold, Frank W.
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024,
  • [26] Longitudinal mediation analysis of time-to-event endpoints in the presence of competing risks
    Tat-Thang Vo
    Davies-Kershaw, Hilary
    Hackett, Ruth
    Vansteelandt, Stijn
    [J]. LIFETIME DATA ANALYSIS, 2022, 28 (03) : 380 - 400
  • [27] Semiparametric regression analysis for time-to-event marked endpoints in cancer studies
    Hu, Chen
    Tsodikov, Alex
    [J]. BIOSTATISTICS, 2014, 15 (03) : 513 - 525
  • [28] Commentary on 'Designing phase II studies in cancer with time-to-event endpoints'
    Case, Doug
    Morgan, Tim
    [J]. CLINICAL TRIALS, 2008, 5 (03) : 222 - 223
  • [29] Comparing and combining biomarkers as principle surrogates for time-to-event clinical endpoints
    Gabriel, Erin E.
    Sachs, Michael C.
    Gilbert, Peter B.
    [J]. STATISTICS IN MEDICINE, 2015, 34 (03) : 381 - 395
  • [30] Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials
    Bellera, Carine A.
    Pulido, Marina
    Gourgou, Sophie
    Collette, Laurence
    Doussau, Adelaide
    Kramar, Andrew
    Dabakuyo, Tienhan Sandrine
    Ouali, Monia
    Auperin, Anne
    Filleron, Thomas
    Fortpied, Catherine
    Le Tourneau, Christophe
    Paoletti, Xavier
    Mauer, Murielle
    Mathoulin-Pelissier, Simone
    Bonnetain, Franck
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) : 769 - 781